TRAVERE THERAPEUTICS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TRAVERE THERAPEUTICS INC NOTE 2.250% 3/0, CUSIP 89422GAA5.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TRAVERE THERAPEUTICS INC NOTE 2.250% 3/0, CUSIP 89422GAA5.